Showing results (861-870 of 1,826) with videos related to

Sort By:
Pageof 183
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|June 1, 1989
Acute thrombotic infarction suppresses metabolic activation of ipsilateral somatosensory cortex: evidence for functional diaschisisM D Ginsberg, Y Castella, W D Dietrich, et al.
Analytical Chemistry|September 15, 2015
Meat Authentication via Multiple Reaction Monitoring Mass Spectrometry of Myoglobin PeptidesAndrew D Watson, Yvonne Gunning, Neil M Rigby, et al.
Postgraduate Medical Journal|January 1, 1992
The relationship between cardiac reserve and survival in critically ill patients receiving treatment aimed at achieving supranormal oxygen delivery and consumptionA C Timmins, M Hayes, E Yau, et al.
Arthritis and Rheumatism|December 1, 1992
Lymphocyte responses to DR4/1-restricted peptides in rheumatoid arthritis. The immunodominant T cell epitope on the 19-kd Mycobacterium tuberculosis proteinP L Tan, S Farmiloe, J Young, et al.
The EMBO Journal|February 1, 1985
New cloning vehicles for transformation of higher plantsG An, B D Watson, S Stachel, et al.
Nanoscale|May 8, 2013
Electrically conductive magnetic nanowires using an electrochemical DNA-templating routeScott M D Watson, Hasan Daw A Mohamed, Benjamin R Horrocks, et al.
Neuroscience|September 1, 2001
The cytosolic antioxidant, copper/zinc superoxide dismutase, attenuates blood-brain barrier disruption and oxidative cellular injury after photothrombotic cortical ischemia in miceG W Kim, A Lewén, J Copin, et al.
The Journal of Biological Chemistry|July 30, 2002
Identifying genes regulated in a Myc-dependent mannerJohn D Watson, Sara K Oster, Mary Shago, et al.
Science & Justice : Journal of the Forensic Science Society|July 1, 1995
Comparison of Cannabis sativa by random amplification of polymorphic DNA (RAPD) and HPLC of cannabinoids: a preliminary studyR Gillan, M D Cole, A Linacre, et al.
Arthritis and Rheumatism|June 1, 2006
Comparison of the response to infliximab or etanercept monotherapy with the response to cotherapy with methotrexate or another disease-modifying antirheumatic drug in patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics RegisterKimme L Hyrich, Deborah P M Symmons, Kath D Watson, et al.
Pageof 183